Our Mission
To improve patient outcomes by developing first-in-class small molecule inhibitors of the Myc oncoprotein as safe and effective treatments for cancer.
To improve patient outcomes by developing first-in-class small molecule inhibitors of the Myc oncoprotein as safe and effective treatments for cancer.
